Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer

Breast Cancer Research and Treatment

Volumn 100, Issue 1, 2006, Pages 109-119

  Kriege, Mieke ^a   Brekelmans, Cecile T M ^a   Obdeijn, Inge Marie ^a   Boetes, Carla ^b   Zonderland, Harmine M ^c   Muller, Sara H ^d   Kok, Theo ^e   Manoliu, Radu A ^f   Besnard, A Peter E ^d   Tilanus Linthorst, Madeleine M A ^a   Seynaeve, Caroline ^a   Bartels, Carina C M ^a   Kaas, Reini ^d   Meijer, Siebren ^f   Oosterwijk, Jan C ^e   Hoogerbrugge, Nicoline ^b   Tollenaar, Rob A E M ^c   Rutgers, Emiel J T ^d   De Koning, Harry J ^a   Klijn, Jan G M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Age; BRCA1; BRCA2; Breast cancer screening; Breast density; Mammography; Menopausal status; MRI; Sensitivity; Specificity

Indexed keywords

ADULT; ARTICLE; BREAST TUMOR; EVALUATION; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MAMMOGRAPHY; MIDDLE AGED; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTION AND FORECASTING; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY; STANDARD;

ADULT; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; NETHERLANDS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 34848885204     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-006-9230-z     Document Type: Article

References (47)

1. Vasen HFA, Haites NE, Evans DGR et al (1998) Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 european family cancer clinics. Eur J Cancer 34:1922-1926 (Pubitemid 28535442)
2. Brekelmans CT, Seynaeve C, Bartels CC et al (2001) Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19:924-930 (Pubitemid 32176266)
3. Scheuer L, Kauff N, Robson M et al (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20:1260-1268 (Pubitemid 34177432)
4. Komenaka IK, Ditkoff BA, Joseph KA et al (2004) The development of interval breast malignancies in patients with BRCA mutations. Cancer 100:2079-2083 (Pubitemid 38580324)
5. Kriege M, Brekelmans CT, Boetes C et al (2001) MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch national study (MRISC). Fam Cancer 1:163-168
6. Kriege M, Brekelmans CT, Boetes C et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437
7. Warner E, Plewes DB, Hill KA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317-1325 (Pubitemid 39223222)
8. Leach MO, Boggis CR, Dixon AK et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769-1778 (Pubitemid 40744657)
9. Kuhl CK, Schrading S, Leutner CC et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469-8476
10. Litherland JC, Stallard S, Hole D et al (1999) The effect of hormone replacement therapy on the sensitivity of screening mammograms. Clin Radiol 54:285-288 (Pubitemid 29237805)
11. Kerlikowske K, Grady D, Barclay J et al (1996) Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 276:33-38 (Pubitemid 26231053)
12. Rosenberg RD, Hunt WC, Williamson MR et al (1998) Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology 209:511-518 (Pubitemid 28503121)
13. Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225:165-175
14. Tabar L, Fagerberg G, Chen HH et al (1995) Efficacy of breast cancer screening by age. New results from the Swedish twocounty trial. Cancer 75:2507-2517
15. Fletcher SW, Black W, Harris R et al (1993) Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 85:1644-1656 (Pubitemid 23315423)
16. Carney PA, Miglioretti DL, Yankaskas BC et al (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138:168-175 (Pubitemid 36231622)
17. Ciatto S, Visioli C, Paci E et al (2004) Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer 90:393-396 (Pubitemid 38250634)
18. Saarenmaa I, Salminen T, Geiger U et al (2001) The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultasonography. Breast Cancer Res Treat 67:117-123 (Pubitemid 32744492)
19. Banks E, Reeves G, Beral V et al (2004) Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study. Br Med J 329:477
20. Tilanus-Linthorst M, Verhoog L, Obdeijn IM et al (2002) A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent falsenegative mammography. Int J Cancer 102:91-95
21. Halapy E, Chiarelli AM, Klar N et al (2005) Accuracy of breast screening among women with and without a family history of breast and/or ovarian cancer. Breast Cancer Res Treat 90:299-305 (Pubitemid 40576844)
22. van Gils CH, Otten JD, Verbeek AL et al (1998) Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, the Netherlands. J Epidemiol Commun Health 52:267-271 (Pubitemid 28176825)
23. Mandelson MT, Oestreicher N, Porter PL et al (2000) Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 92:1081-1087 (Pubitemid 30616482)
24. Kavanagh AM, Mitchell H, Giles GG (2000) Hormone replacement therapy and accuracy of mammographic screening. Lancet 355:270-274 (Pubitemid 30068519)
25. Blanks RG, Moss SM, McGahan CE et al (2000) Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. Br Med J 321:665-669
26. Kavanagh AM, Cawson J, Byrnes GB et al (2005) Hormone replacement therapy, percent mammographic density, and sensitivity of mammography. Cancer Epidemiol Biomarkers Prev 14:1060-1064 (Pubitemid 40656448)
27. Thurfjell EL, Holmberg LH, Persson IR (1997) Screening mammography: sensitivity and specificity in relation to hormone replacement therapy. Radiology 203:339-341 (Pubitemid 27176202)
28. Sardanelli F, Giuseppetti GM, Panizza P et al (2004) Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol 183:1149-1157 (Pubitemid 44185114)
29. Bluemke DA, Gatsonis CA, Chen MH et al (2004) Magnetic resonance imaging of the breast prior to biopsy. JAMA 292:2735-2742 (Pubitemid 39628252)
30. Berg WA, Gutierrez L, NessAiver MS et al (2004) Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233:830-849
31. Harms SE (1998) Breast magnetic resonance imaging. Semin Ultrasound CT MR 19:104-120
32. Heywang-Kobrunner SH, Viehweg P, Heinig A et al (1997) Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 24:94-108 (Pubitemid 27165349)
33. Kinkel K, Hylton NM (2001) Challenges to interpretation of breast MRI. J Magn Reson Imaging 13:821-829 (Pubitemid 32479937)
34. Kuhl CK, Bieling HB, Gieseke J et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203:137-144 (Pubitemid 27142721)
35. Muller-Schimpfle M, Ohmenhauser K, Stoll P et al (1997) Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 203:145-149 (Pubitemid 27142722)
36. Claus EB, Risch NJ, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Cancer 73:643-651
37. American College of Radiology (1995) Illustrated breast imaging reporting and data system (BI-RADS). 3
38. Berg WA, Campassi C, Langenberg P et al (2000) Breast imaging reporting and data system: inter- and intraobserver variability in feature analysis and final assessment. AJR Am J Roentgenol 174:1769-1777 (Pubitemid 30346755)
39. Lee-Han H, Cooke G, Boyd NF (1995) Quantitative evaluation of mammographic densities: a comparison of methods of assessment. Eur J Cancer Prev 4:285-292
40. Sivaramakrishna R, Obuchowski NA, Chilcote WA et al (2001) Automatic segmentation of mammographic density. Acad Radiol 8:250-256 (Pubitemid 32666465)
41. Ooms EA, Zonderland HM, Eijkemans MJC et al (2006) Mammography: inter-observer variability in breast density assesment (abstract). Fifth international meeting: endocrine treatment prevention of breast ABD gynaecological cancers
42. Kaas R, Kroger R, Hendriks JH et al (2004) The significance of circumscribed malignant mammographic masses in the surveillance of BRCA 1/2 gene mutation carriers. Eur Radiol 14: 1647-1653 (Pubitemid 39232896)
43. Buist DS, Porter PL, Lehman C et al (2004) Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst 96:1432-1440 (Pubitemid 39429667)
44. Tilanus-Linthorst MM, Kriege M, Boetes C et al (2005) Hereditary breast cancer growth rates and its impact on screening policy. Eur J Cancer 41:1610-1617 (Pubitemid 40981844)
45. Day NE, Williams DR, Khaw KT (1989) Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 59:954-958 (Pubitemid 19155717)
46. Kriege M, Brekelmans CTM, Boetes C et al (2006, in press) Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Cancer
47. Adem C, Reynolds C, Soderberg CL et al (2003) Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Cancer 97:1-11 (Pubitemid 36033857)